RxDoctor Payments Data

Hendricks Agwu

Psychiatric/Mental Health · Lewisville, TXNPI 1386978864

Payments from drug & device makers

$1,811in general payments, 2019–2025

Across 97 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$400
  • Neurocrine Biosciences, Inc.$264
  • Teva Pharmaceuticals USA, Inc.$226
  • AbbVie$185
  • Johnson & Johnson$146
  • Otsuka America Pharmaceutical, Inc.$121
  • plus $468 from 10 others

What the payments were for

  • Food & beverage$1,76698%
  • Education$452%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,811 in reported general payments places this provider in the 70th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$2,101
Medicare patients
16
Services billed
32

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl29$59,044
RexultiBrexpiprazole13$18,930
Lurasidone Hcl52$12,544
Duloxetine Hcl145$6,523
BelsomraSuvorexant14$5,942
Quetiapine Fumarate ErQuetiapine Fumarate48$5,504
Aripiprazole155$4,262
Atomoxetine Hcl25$4,139
Bupropion XlBupropion Hcl143$3,509
Trazodone Hcl310$2,863
Desvenlafaxine Succinate ErDesvenlafaxine Succinate31$2,173
Hydroxyzine Hcl101$2,142
Quetiapine Fumarate127$2,138
Clonazepam189$1,760
Ziprasidone Hcl29$1,689

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$185$59,04429 claims
Otsuka America Pharmaceutical, Inc.Rexulti$121$18,93013 claims
Almatica Pharma LLCSertraline Hcl$41$757142 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Lewisville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →